Differential expression of type 1 angiotensin II receptor mRNA and aldosterone responsiveness to angiotensin in aldosterone-producing adenoma

Molecular and Cellular Endocrinology

Volumn 152, Issue 1-2, 1999, Pages 47-55

  Chen, Yung Ming ^a   Wu, Kwan Dun ^a   Hu Tsai, Mi I ^a   Chu, Jan Show ^a   Lai, Ming Kuen ^a   Hsieh, Bor Shen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Aldosterone responsiveness; Angiotensin II receptor; Primary aldosteronism; Zona fasciculata; Zona glomerulosa

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR;

ADRENAL CORTEX ADENOMA; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ARTICLE; CELL COMPOSITION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; GENE EXPRESSION; HISTOPATHOLOGY; HORMONE RESPONSE; HUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SODIUM RESTRICTION; STANDING;

ADENOMA; ADRENAL GLAND NEOPLASMS; ALDOSTERONE; ANGIOTENSIN II; HUMANS; HYPERANDROGENISM; IN SITU HYBRIDIZATION; POLYMERASE CHAIN REACTION; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER;

EID: 0033603589     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00059-3     Document Type: Article

References (25)

1. Banks W.A., Kastin A.J., Biglieri E.G., Ruiz A.E. Primary adrenal hyperplasia: A new subset of primary hyperaldosteronism. J. Clin. Endocrinol. Metab. 58:1984;783-785.
2. Bergsma D.J., Ellis C., Kumar C., Nuthulaganti P., Kersten H., Elshourbagy N., Griffin E., Stade J.M., Aiyar N. Cloning and characterization of a human angiotensin II type 1 receptor. Bichem. Biophys. Res. Commun. 183:1992;989-995.
3. Brown G., Douglas J., Bravo E. Angiotensin II receptors and in vitro aldosterone responses of aldosterone-producing adenomas, adjacent non-tumorous tissue, and normal human adrenal glomerulosa. J. Clin. Endocrinol. Metab. 51:1980;718-723.
4. Chen Y.-M., Wu K.-D., Hung K.-Y., Pu Y.-S., Hsieh B.-S. Quantitative analysis of messenger ribonucleic acid encoding natriuretic peptide receptors in aldosterone-producing adenoma. Mol. Cell. Endocrinol. 111:1995;139-146.
5. Cook M.D., Phillips M.I., Cook V.I., Kimura B., Wilcox C.S. Angiotensin II receptor subtypes on adrenal adenoma in primary hyperaldosteronism. J. Am. Soc. Nephrol. 4:1993;111-116.
6. Davies E., Bonnardeaux A., Plouin P.-F., Corvol P., Clauser E. Somatic mutations of the angiotensin II (ATT) receptor gene are not present in aldosterone-producing adenoma. J. Clin. Endocrinol. Metab. 82:1997;611-615.
7. Ganguly A., Melada G.A., Luetscher J.A., Dowdy A.J. Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia. J. Clin. Endocrinol. Metab. 37:1973;765-775.
8. Gonzalez-Garcia C., Keiser H.R. Angiotensin II and angiotensin converting enzyme binding in human adrenal gland and pheochromocytomas. J. Hypertens. 8:1990;433-441.
9. Gordon R.-D., Hamlet S.-M., Tunny T.-J., Klemm S.A. Aldosterone-producing adenomas responsive to angiotensin pose problems in diagnosis. Clin. Exp. Pharmacol. Physiol. 14:1987;175-179.
10. Ho S.-N., Hunt H.-D., Horton R.-M., Pullen J.K., Pease L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 77:1989;51-59.
11. Irony I., Kater E., Biglieri E.G., Shackleton C.H.L. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. Am. J. Hypertens. 3:1990;576-582.
12. Kambayashi Y., Bardhan S., Takahashi K., Tsuzuki S., Inui H., Hamakubo T., Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J. Biol. Chem. 268:1993;24543-24546.
13. Klemm S.A., Ballantine D.M., Tunny T.J., Stowasser M., Gordon R.D. PCR-SSCP analysis of the angiotensin II type 1 receptor gene in patients with aldosterone-producing adenomas. Clin. Exp. Pharmacol. Physiol. 22:1995;457-459.
14. Neville A.M., Symington T. Pathology of primary aldosteronism. Cancer. 19:1966;1854-1868.
15. Rainey W.E., Bird I.M., Mason J.I., Carr B.R. Angiotensin II receptors on human fetal adrenal cells. Am. J. Obstet. Gynecol. 167:1992;1679-1685.
16. Sasano H., Okamoto M., Sasano N. Immunochemical study of cytochrome P45011β-hydroxylase in human adrenal cortex with mineraloand glucocorticoid excess. Virchows. Arch. [A]. 413:1988;313-318.
17. Slaton E. Jr., Schambelan M., Biglieri E.G. Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma. J. Clin. Endocrinol. Metab. 29:1969;239-250.
18. Torpy D.J., Stratakis C.A., Gordon R.D. Linkage analysis of familial hyperaldosteronism type II - absence of linkage to the gene encoding the angiotensin II receptor type 1. J. Clin. Endocrinol. Metab. 83:1998;1046.
19. Tremblay A., Parker K.L., Lehoux J.G. Dietary potassium supplementation and sodium restriction stimulate aldosterone synthase but not 11β-hydroxylase P-450 messenger ribonucleic acid accumulation in rat adrenals and require angiotensin II production. Endocrinology. 130:1992;3152-3158.
20. Tunny T.J., Gordon R.D., Klemm S.A., Cohn D. Histological and biochemical distinctiveness of atypical aldosterone-producing adenomas responsive to upright posture and angiotensin. Clin. Endocrinol. 34:1991;363-369.
21. Tunny T.J., Klemm S.A., Stowasser M., Gordon R.D. Angiotensin-responsive aldosterone-producing adenomas: Postoperative disappearance of aldosterone response to angiotensin. Clin. Exp. Pharmacol. Physiol. 20:1993;306-309.
22. Ullian M.E., Linas S.L. Angiotensin II surface receptor coupling to inositol triphosphate formation in vascular smooth muscle cells. J. Biol. Chem. 265:1990;195-200.
23. White P.C. Disorders of aldosterone biosynthesis and action. New Engl. J. Med. 331:1994;250-258.
24. Whitebread S., Mele M., Kamber B., de Gasparo M. Preliminary biochemical characterisation of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 163:1989;284-291.
25. Wu K.-D., Chen Y.-M., Chu J.-S., Hung K.-Y., Hsieh T.-S., Hsieh B.S. Zona fasciculata-like cells determine the response of plasma aldosterone to metoclopramide and aldosterone synthase messenger ribonucleic acid level in aldosterone-producing adenoma. J. Clin. Endocrinol. Metab. 80:1995;783-789.